Project Number 1U01AG076480-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator WATTERSON, DANIEL MARTIN Principal Investigator First Name DANIEL MARTIN Principal Investigator Last Name WATTERSON Awardee Organization NORTHWESTERN UNIVERSITY AT CHICAGO Awardee State Illinios Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $1,546,977 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
